| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |